Can an infant develop shingles, particularly if exposed to the varicella-zoster virus (VZV) in utero or through contact with an infected individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Infants Get Shingles?

Yes, infants can develop shingles (herpes zoster), though it is rare and typically occurs only after in utero exposure to varicella-zoster virus (VZV) during pregnancy. 1

Mechanism of Infant Shingles

  • Infants exposed to VZV in utero during 13-36 weeks' gestation have a 0.8-1.7% risk of developing herpes zoster during infancy or early childhood due to viral latency established during fetal infection. 1, 2

  • The virus establishes latency in neuronal ganglia during prenatal infection, even if the infant appears asymptomatic at birth, and can reactivate months to years later causing shingles. 1

  • Infants who acquire chickenpox during the first year of life after birth also have an increased risk of developing shingles, though this is less common than in utero acquisition. 1

Clinical Presentation in Infants

  • Shingles in infants typically presents as vesicular rash in a dermatomal distribution, similar to adults, though the presentation may be atypical. 3

  • Case reports document infants developing zoster-like lesions as early as 3-7 months of age following maternal varicella infection during the second trimester of pregnancy. 3

  • Laboratory confirmation shows four-fold rise in VZV IgG antibody or positive VZV IgM antibody in affected infants. 3

Risk Factors for Infant Shingles

  • The highest risk occurs when maternal varicella infection happens between 13-20 weeks' gestation (2% risk of congenital varicella syndrome), with lower risk at 0-12 weeks (0.4% risk). 2

  • Maternal herpes zoster during pregnancy does not cause congenital varicella syndrome or increase infant shingles risk, as no cases were reported among 366 infants whose mothers had zoster during pregnancy. 1

  • Immunocompromised infants have higher risk of severe disease and complications. 1

Important Clinical Distinctions

  • Infants cannot develop shingles without prior VZV exposure—either in utero or through postnatal chickenpox infection. 1

  • Neonatal varicella (chickenpox in newborns) is distinct from infant shingles and occurs when mothers develop varicella from 5 days before to 2 days after delivery, with 17-30% of exposed newborns developing severe infection. 1

  • Infants exposed prenatally to VZV may have measurable varicella-specific IgM antibody during the newborn period or persistent IgG immunity after age 1 year without any history of postnatal chickenpox. 1

Management Considerations

  • Acyclovir treatment is effective for infant shingles, with case reports showing rapid healing of skin lesions without sequelae. 3

  • For immunocompromised infants with VZV infections, IV acyclovir 5-10 mg/kg/dose three times daily for 7-14 days or oral acyclovir 20 mg/kg/dose three times daily for 7-14 days is recommended. 4

  • Varicella-zoster immune globulin (VZIG) should be administered to newborns when maternal varicella occurs peripartum (5 days before to 2 days after delivery) to prevent severe neonatal disease. 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Congenital Varicella Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Herpes zoster in infancy after intrauterine exposure to varicella zoster virus: report of two cases.

Journal of the Formosan Medical Association = Taiwan yi zhi, 1994

Guideline

Herpetic Whitlow in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Prenatal Diagnosis and Management of Congenital Varicella

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.